China Dulaglutide Manufacturers Factory Suppliers
-
Dulaglutide - Diabetes (recombinant Route), Diabetes Bulk , CAS No.: 923950-08-7
DULAGLUTIDE contains dulaglutide, a human GLP-1 receptor agonist. The molecule is a fusion protein that consists of 2 identical, disulfide-linked chains, each containing an N-terminal GLP-1
-
Semaglutide– Diabetes (recombinant Route),diabetes Bulk,CAS No.: 910463-68-2
Semaglutide is a prescription medicine used to treat the symptoms of Type 2 Diabetes Mellitus. Semaglutide may be used alone or with other medications.
-
PegFilgrastim– A Long Lasting RhG-CSF, CAS No.: 208265-92-3,Bulk
Pegfilgrastim (pegfilgrastim) is a colony-stimulating factor, a man-made form of a protein that stimulates the growth of white blood cells, used to decrease the incidence of infection
-
Fosaprepitant Dimeglumine, CAS No.: 265121-04-8,Bulk
Fosaprepitant dimeglumine for injection is a sterile, lyophilized formulation containing fosaprepitant dimeglumine, a prodrug of aprepitant, a substance P/neurokinin-1 (NK1) receptor antagonist
-
Daratumumab (with Recombinant Human Hyaluronidase) API, CAS No.: 945721-28-8
Name: Daratumumab (with recombinant human hyaluronidase). CD38 inhibitor with recombinant human hyaluronidase. INDICATIONS: Multiple myeloma
-
Bone Repair Material With RhBMP-2 - Bone Repair,CAS: 64421-28-9
Based on the simultaneous development of innovative drugs and generic drugs, the company focuses on the development of recombinant proteins, antibodies, and combination products of biological and
-
Recombinant Human Hyaluronidase, CAS:37326-33-3
By breaking down hyaluronic acid in skin tissue, hyaluronic can increase membrane permeability and improve the absorption and dispersion of parenterally administered fluids and drugs into tissue.
-
Liraglutide (recombinant Route), Diabetes Bulk, CAS No.: 204656-20-2
Liraglutide is a prescription medicine used to treat the symptoms of Type 2 Diabetes Mellitus. Liraglutide may be used alone or with other medications.
-
RhIL-11 (Oprelvekin)– A Drug To Increase Platelet Count, CAS No.: 145941-26-0, Recombinant Human Interleukin-11
Generic Name: Oprelvekin. Chemical Name: Human Interleukin-11 for Injection. The only drug approved by FDA for prevention and treatment of Chemoradiotherapy-induced thrombocytopenia..
-
Palonosetron Hydrochloride– Anti-emesis After Chemotherapy Or Radiotherapy, CAS No.: 135729-62-3
Generic Name: Palonosetron Hydrochloride injection. The quality and efficacy consistency of generic drugs were evaluated.. The second generation 5-HT3 receptor antagonist, super antagonistic, long -
-
RhG-CSF (Filgrastim) (Recombinant Human Granulocyte Colony-Stimulating Factor) – A Drug To Increase White Blood Cell Count, CAS No.: 121181-53-1
Generic Name: Filgrastim. Chemical Name: Human Granulocyte-Colony Stimulating Factor (hG-CSF) Injection. The first human granulocyte stimulating factor in China; Approved by German GMP international
-
RhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) – A New Bone Repair Material, Registered As An Implanted Medical Device, API
Chemical Name: Recombinant Human Bone Morphogenetic Protein-2. A new type bone repairing material which has biological activity..
Jan 15, 2019 · Trulicity is the trade name of dulaglutide, a type 2 diabetes medication made by Eli Lilly. Trulicity is part of a class of drugs called GLP-1 receptor agonists Other GLP-1 receptor...
Aug 16, 2021 · Dulaglutide helps your body to release its own insulin just when you need it, improving blood glucose control throughout the week. Unlike insulin it will not cause weight...
Jan 09, 2015 · Dulaglutide is a GLP-1 RA that has demonstrated A 1c reduction of ∼0.7%–1.5% and reductions of FPG by 13–43 mg/dL, as monotherapy or in combination, at 0.75 and 1.5 mg once-weekly...
Dulaglutide and liraglutide have similar rates of nausea, while albiglutide has a lower rate of nausea than liraglutide [23 R]. An open-label observational study evaluated the safety and...
Dulaglutide is a long-acting glucagon-like peptide 1 (GLP-1) receptor agonist that augments glucose-dependent insulin secretion, and slows gastric emptying. Indications and dose Type...
Jun 21, 2021 · Dulaglutide causes dose- and treatment duration-dependent thyroid C-cell tumors (adenomas and carcinomas) in male and female rats after lifetime exposure. Unknown whether dulaglutide...
